BioCatalyst

LTRN — Lantern Pharma Inc. catalysts

1 verified catalyst event(s) for Lantern Pharma Inc. (ticker LTRN). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-12-01 — A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Aden · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced
Phase 2 · Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung
 LTRN Lantern Pharma Inc. LP-300, Pemetrexed, Carboplatin ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.